bluebird bio Inc. (BLUE): Balans kapitallashuviga qarzlar

bluebird bio, Inc. (BLUE) kompaniyasining korporativ logotipi

bluebird bio, Inc. (BLUE) og'ir genetik patologiyalar uchun innovatsion davolash usullarini ishlab chiqadi hamda tasdiqlangan dori vositalarini tijoratlashtirish va strategik sherikliklar orqali daromad keltiradi. Ushbu terapiyalarni yetkazib berish xavfsiz kriogen ta'minot zanjirlariga tayanadi. AQShda Lyfgenia va Zynteglo sotuvlari aksiyaning yuqoriga qarab harakatlanishiga turtki bermoqda. GURU.Markets terminali kompaniyaning kapitalizatsiyasiga nisbatan qarzdorlik grafigini namoyish etadi, bunda oxirgi parametr 0.00 bo'lib, u biznesning moliyaviy barqarorligini baholashga yordam beradi.

BLUE bluebirdbio.com: Qarzning balans kapitallashuviga nisbati 04.07.2022 - 07.06.2025 oraligʻida

bluebird bio Inc. (BLUE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi bluebird bio, Inc.|BLUE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi bluebird bio, Inc|BLUE - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar bluebird bio|BLUE - Kompaniyaning balans qiymati|Kapitallashuvning sof aktivlarga nisbati bluebirdbio.com|BLUE - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati bluebird bio, Inc.|BLUE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Bluebird Bio|BLUE - Kompaniya qarzlari|Balans kapitallashuviga qarzlar bluebird bio, Inc|BLUE - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi bluebird bio
Kompaniyaning fundamental tahlili:bluebird bio, Inc.
bluebird bio Inc. yetakchi tovari

Ushbu koeffitsiyent balansdagi umumiy majburiyatlarning kapitalga nisbatan ulushini aks ettiradi. Investorlar undan kredit riski va o'sish uchun qarz mablag'laridan foydalanish samaradorligi o'rtasidagi muvozanatni baholash uchun foydalanadilar. Umumiy qarzdorlikning kitob kapitalizatsiyasiga nisbatan ulushidagi o'zgarishlarni tahlil qilish orqali moliyalashtirish tuzilmasining barqarorligini aniqlash mumkin. bluebird bio, Inc. (BLUE) uchun ushbu ko'rsatkich kuchli raqobatchilarga qarshi kurashda resurslar yetishmovchiligi sababli juda muhimdir. Gen terapiyasini joriy etishning yuqori xarajatlari kompaniyani yashab qolish uchun kapitalning mavjudligiga bog'liq qiladi.

bluebird bio, Inc. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Balans kapitallashuviga qarzlar|RGEN: Qarzning balans kapitallashuviga nisbati|Avidity (RNA) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati CRISPR|WGS (GeneDx Holdings Corp.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ultragenyx.com|Beam Therapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Sarepta Therapeutics (SRPT)|Balans kapitallashuviga qarzlar Twist Bio TWST|Qarzning balans kapitallashuviga nisbati 10x TXG|Balans kapitallashuviga qarzlar NTLA (Intellia Therapeutics)|STOK: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati BioLife Solutions BLFS|Wave Life Sciences Ltd (WVE) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Maze Tx (MAZE)|Qarzning balans qiymatiga nisbati Sionna Corp (SION)|Prime Medicine, Inc. (PRME) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati tayshagtx.com (TSHA)|Balans kapitallashuviga qarzlar uniQure QURE|Qarzning balans kapitallashuviga nisbati MeiraGTx Holdings MGTX|Balans kapitallashuviga qarzlar RGNX (Regenxbio)|SLDB: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati OCGN|Balans qiymatiga qarzlar pacb.com|BNTC - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Design Therapeutics Inc|RCKT (Rocket Pharmaceuticals Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar FDMT (4D Molecular Corp)|LXEO - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Korro Bio Inc. KRRO|EDIT: Balans kapitallashuviga qarzlar|Silence Therapeutics PLC (SLN) - Qarzning balans qiymatiga nisbati|proqr.com - Qarzning balans qiymatiga nisbati|Codexis (CDXS) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Sangamo Therapeutics|Qarzning balans kapitallashuviga nisbati NAUT|Qarzning balans kapitallashuviga nisbati Metagenomi (MGX)|Qarzning balans kapitallashuviga nisbati Precision BioSciences Inc. DTIL|Qarzning balans qiymatiga nisbati GBIO (Generation Bio)|Balans kapitallashuviga qarzlar Boundless Bio Inc BOLD|XCUR (Exicure Corp) - Balans kapitallashuviga qarzlar|IMNN - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar phiopharma.com|MBIO (Mustang Bio) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati TransCode Therapeutics Inc. (RNAZ)|Qarzning balans qiymatiga nisbati Bionano|Balans kapitallashuviga qarzlar APDN|Balans kapitallashuviga qarzlar immunoprecise.com (IPA)|Balans kapitallashuviga qarzlar Omega Therapeutics, Inc. OMGA|Singular Genomics Systems, Inc. - Qarzning balans kapitallashuviga nisbati|RGLS - Qarzning balans kapitallashuviga nisbati|Syros Pharmaceuticals, Inc (SYRS) - Qarzning balans kapitallashuviga nisbati|TBIO: Qarzning balans qiymatiga nisbati|traconpharma.com (TCON) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar UBX (Unity Biotechnology, Inc.)